Evidence map›Paper›PMID 28462021›Full record

ArticlePeerJ2017

Differential transcript profile of inhibitors with potential anti-venom role in the liver of juvenile and adult

Cícera Maria Gomes, Karen de Morais-Zani, Stephen Lu, Diego de Souza Buarque, Glória Regina Cardoso Braz, Kathleen Fernandes Grego, Aparecida Sadae Tanaka, Anita Mitico Tanaka-Azevedo

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Genome of venomous caterpillarProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Cícera Maria GomesLaboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.
Karen de Morais-ZaniLaboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.
Stephen LuDepartamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, Brazil.
Diego de Souza BuarqueDepartamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, Brazil.
Glória Regina Cardoso BrazDepartamento de Bioquímica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Kathleen Fernandes GregoLaboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.
Aparecida Sadae Tanaka *Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular, São Paulo, Brazil.
Anita Mitico Tanaka-Azevedo *Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRInstituto Butantan · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSnakes belonging to the

methodsIn order to identify anti-venom molecules, we construct a cDNA library from the liver of

resultsThe results revealed a 30-fold increase of gamma-phospholipase A DISCUSSION: The results suggest the up-regulation of different inhibitors observed in the adult snakes might be a physiological adaptation to the recurrent contact with their own and even other snake's venoms throughout its lifespan. This is the first comparative analysis of ontogenetic variation of expression profiles of plasmatic proteins with potential anti-venom activities of the venomous snake

Indexed as

Anti-venomBothrops jararacaGene expressionPlasmatic proteinProtease inhibitorsSnake plasma

Identifiers

PMID28462021
PMCPMC5410159
OpenAlexW2608303911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.